Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

Giuseppe Derosa, Arrigo F.G Cicero, Antonio Gaddi, Pietro D Ragonesi, Elena Fogari, Gianandrea Bertone, Leonardina Ciccarelli, Mario N Piccinni
  • Clinical Therapeutics, May 2004, Elsevier
  • DOI: 10.1016/s0149-2918(04)90074-4

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Arrigo FG CICERO